Search Results - Tesa Severson

Refine Results
  1. 1
    Evidence for Archaic Asian Ancestry on the Human X Chromosome

    Evidence for Archaic Asian Ancestry on the Human X Chromosome by Daniel Garrigan, Zahra Mobasher, Tesa Severson, Jason A. Wilder, Michael F. Hammer

    Published 2004
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    A novel DNA sequence database for analyzing human demographic history

    A novel DNA sequence database for analyzing human demographic history by Jeffrey D. Wall, Murray P. Cox, Fernando L. Méndez, August E. Woerner, Tesa Severson, Michael F. Hammer

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities

    CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities by Tomasz Ahrends, Julia Busselaar, Tesa Severson, Nikolina Bąbała, Evert de Vries, Astrid Bovens, Lodewyk F.A. Wessels, Fred van Leeuwen, Jannie Borst

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment

    Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment by Karin Beelen, Mark Opdam, Tesa Severson, Rutger H.T. Koornstra, Andrew Vincent, Jelle Wesseling, Jettie J.F. Muris, Els M.J.J. Berns, Jan B. Vermorken, P. J. van Diest, Sabine C. Linn

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

    PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenop... by Karin Beelen, Mark Opdam, Tesa Severson, Rutger H.T. Koornstra, Andrew Vincent, Jelle Wesseling, Jettie J.F. Muris, Els M.J.J. Berns, Jan B. Vermorken, P. J. van Diest, Sabine C. Linn

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations

    Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations by Sebastian Gregoricchio, Aleksandar Kojić, Marlous Hoogstraat, Karianne Schuurman, Suzan Stelloo, Tesa Severson, Tracy A. O’Mara, Marjolein Droog, Abhishek A. Singh, Dylan M. Glubb, Lodewyk F.A. Wessels, Michiel Vermeulen, Flora E. van Leeuwen, Wilbert Zwart

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

    ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors by Katrien Berns, Joseph J. Caumanns, E. Marielle Hijmans, Annemiek M.C. Gennissen, Tesa Severson, Bastiaan Evers, G. Bea A. Wisman, Gert Jan Meersma, Cor Lieftink, Roderick L. Beijersbergen, Hiroaki Itamochi, Ate G.J. van der Zee, Steven de Jong, René Bernards

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting

    The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting by Tesa Severson, Denise M. Wolf, Christina Yau, Justine Peeters, Diederik Wehkam, Philip C. Schouten, Suet‐Feung Chin, Ian J. Majewski, Magali Michaut, Astrid Bosma, Bernard Pereira, Tycho Bismeijer, Lodewyk F.A. Wessels, Carlos Caldas, René Bernards, Iris Simón, Annuska M. Glas, Sabine C. Linn, Laura van ‘t Veer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential

    BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential by Tesa Severson, Justine Peeters, Ian J. Majewski, Magali Michaut, Astrid Bosma, Philip C. Schouten, Suet‐Feung Chin, Bernard Pereira, Mae A. Goldgraben, Tycho Bismeijer, Roelof J.C. Kluin, Jettie J.F. Muris, Karin Jirström, Ron Kerkhoven, Lodewyk F.A. Wessels, Carlos Caldas, René Bernards, Iris Simón, Sabine C. Linn

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors

    Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors by Parisa Mazrooei, Ken J. Kron, Yanyun Zhu, Stanley Zhou, Giacomo Grillo, Tahmid Mehdi, Musaddeque Ahmed, Tesa Severson, Paul Guilhamon, Nicholas Sinnott Armstrong, Vincent Huang, Takafumi N. Yamaguchi, Michael Fraser, Theodorus van der Kwast, Paul C. Boutros, Housheng Hansen He, Andries M. Bergman, Robert G. Bristow, Wilbert Zwart, Mathieu Lupien

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

    The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair by Ayesha A. Shafi, Christopher McNair, Jennifer J. McCann, Mohammed Alshalalfa, Anton Shostak, Tesa Severson, Yanyun Zhu, Andries M. Bergman, Nicolas Gordon, Amy C. Mandigo, Saswati N. Chand, Peter Gallagher, Emanuela Dylgjeri, Talya S. Laufer, Irina A. Vasilevskaya, Matthew J. Schiewer, Michael Brunner, Felix Y. Feng, Wilbert Zwart, Karen E. Knudsen

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

    DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial by Denise M. Wolf, Christina Yau, Ashish Sanil, Annuska M. Glas, Emanuel F. Petricoin, Julia Wulfkuhle, Tesa Severson, Sabine C. Linn, Lamorna Brown Swigart, Gillian L. Hirst, Meredith Buxton, Angela DeMichele, Nola M. Hylton, Fraser Symmans, Douglas Yee, Melissa Paoloni, Laura J. Esserman, Don Berry, Hope S. Rugo, Olufunmilayo I. Olopade, Laura van ‘t Veer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-<i>trans</i> retinoic acid in acute myeloid leukemia across subtypes

    Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-<i>trans</i> retinoic acid in acute myeloid leukemia acro... by Kimberly N. Smitheman, Tesa Severson, Satyajit Rajapurkar, Michael T. McCabe, Natalie O. Karpinich, James J. Foley, Melissa B. Pappalardi, Ashley M. Hughes, Wendy S. Halsey, Elizabeth Thomas, Christopher Traini, Kelly Federowicz, Jenny Laraio, Fredrick M. Mobegi, Geraldine Ferron‐Brady, Rabinder Prinjha, Christopher L. Carpenter, Ryan G. Kruger, Lodewyk F.A. Wessels, Helai P. Mohammad

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Acquired <i>TNFRSF14</i> Mutations in Follicular Lymphoma Are Associated with Worse Prognosis

    Acquired <i>TNFRSF14</i> Mutations in Follicular Lymphoma Are Associated with Worse Prognosis by K-John Cheung, Nathalie A. Johnson, Joslynn G. Affleck, Tesa Severson, Christian Steidl, Susana Ben‐Neriah, Jacqueline E. Schein, Ryan D. Morin, Richard Moore, Sohrab P. Shah, Hong Qian, Jessica E. Paul, Adèle Telenius, Thomas Relander, Wan L. Lam, Kerry J. Savage, Joseph M. Connors, Carolyn J. Brown, Marco A. Marra, Randy D. Gascoyne, Douglas E. Horsman

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

    Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer by Tesa Severson, Yongsoo Kim, Stacey E. P. Joosten, Karianne Schuurman, Petra van der Groep, Cathy B. Moelans, Natalie D. ter Hoeve, Quirine F. Manson, John W.M. Martens, Carolien H. M. van Deurzen, Ellis Barbé, Ingrid Hedenfalk, Peter Bult, Vincent T.H.B.M. Smit, Sabine C. Linn, P. J. van Diest, Lodewyk F.A. Wessels, Wilbert Zwart

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival

    Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival by Marcelo Sobral‐Leite, Koen Van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K. Hooijer, Hugo M. Horlings, Tesa Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M. Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino‐Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J. van de Vijver, René Bernards, Irene L. Andrulis, Marleen Kok, Karin E. de Visser, Marjanka K. Schmidt

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer

    Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer by Stanley Zhou, James R. Hawley, Fraser Soares, Giacomo Grillo, Mona Teng, Seyed Ali Madani Tonekaboni, Junjie T. Hua, Ken J. Kron, Parisa Mazrooei, Musaddeque Ahmed, Christopher Arlidge, Hwayoung Yun, Julie Livingstone, Vincent Huang, Takafumi N. Yamaguchi, Shadrielle M. G. Espiritu, Yanyun Zhu, Tesa Severson, Alex Murison, Sarina Cameron, Wilbert Zwart, Theodorus van der Kwast, Trevor J. Pugh, Michael Fraser, Paul C. Boutros, Robert G. Bristow, Housheng Hansen He, Mathieu Lupien

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

    Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution by Sohrab P. Shah, Ryan D. Morin, Jaswinder Khattra, Leah Prentice, Trevor J. Pugh, Angela Burleigh, Allen Delaney, Karen A. Gelmon, Ryan Guliany, Janine Senz, Christian Steidl, Robert A. Holt, Steven J.M. Jones, Mark Sun, Gillian Leung, Richard A. Moore, Tesa Severson, Greg Taylor, Andrew E. Teschendorff, Kane Tse, Gulisa Turashvili, Richard Varhol, Robin M. Warren, Peter H. Watson, Yongjun Zhao, Carlos Caldas, David G. Huntsman, Martin Hirst, Marco A. Marra, Samuel Aparício

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer

    Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer by Stefan Prekovic, Karianne Schuurman, Isabel Mayayo‐Peralta, Anna G. Manjón, Mark J. Buijs, Selçuk Yavuz, Max D. Wellenstein, Alejandro Barrera, Kim Monkhorst, Anne Huber, Ben Morris, Cor Lieftink, Theofilos Chalkiadakis, Ferhat Alkan, Joana Silva, Balázs Győrffy, Liesbeth Hoekman, Bram van den Broek, Hans Teunissen, Donna O. Debets, Tesa Severson, Jos Jonkers, Timothy E. Reddy, Karin E. de Visser, William J. Faller, Roderick L. Beijersbergen, Maarten Altelaar, Elzo de Wit, René H. Medema, Wilbert Zwart

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors

    Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors by Steven J.M. Jones, Janessa Laskin, Yvonne Y. Li, Obi L. Griffith, Jianghong An, Mikhail Bilenky, Yaron S.N. Butterfield, Timothée Cezard, Eric Chuah, Richard Corbett, Anthony P. Fejes, Malachi Griffith, John Yee, Montgomery Martin, Michael Mayo, Nataliya Melnyk, Ryan D. Morin, Trevor J. Pugh, Tesa Severson, Sohrab P. Shah, Margaret Sutcliffe, Angela Tam, Jefferson Terry, Nina Thiessen, Thomas A. Thomson, Richard Varhol, Thomas Zeng, Yongjun Zhao, Richard A. Moore, David G. Huntsman, İnanç Birol, Martin Hirst, Robert A. Holt, Marco A. Marra

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: